Worth?Aside from all the back and forth, and egos running galore, with price/sales at 1.3, and a small bump toward lower losses moving forward, it is not unreasonable to look for a SP in the range of $4.50-$6.50 SP..
They will need however, at some point, to stop expanding and continuing their cash burn, and to concentrate on growing their patient base with the resources they have already acquired. In other words, give the aquisitions a rest for a while.
Until we get some clarity on this issue, I would expect the SP to remain stagnent.